HomeComparePRTT vs JNJ

PRTT vs JNJ: Dividend Comparison 2026

PRTT yields 3636.36% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRTT wins by $2866463184412.32M in total portfolio value
10 years
PRTT
PRTT
● Live price
3636.36%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2866463184412.34M
Annual income
$2,719,355,147,267,598,000.00
Full PRTT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PRTT vs JNJ

📍 PRTT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRTTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRTT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRTT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRTT
Annual income on $10K today (after 15% tax)
$309,090.91/yr
After 10yr DRIP, annual income (after tax)
$2,311,451,875,177,458,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PRTT beats the other by $2,311,451,875,177,457,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRTT + JNJ for your $10,000?

PRTT: 50%JNJ: 50%
100% JNJ50/50100% PRTT
Portfolio after 10yr
$1433231592206.18M
Annual income
$1,359,677,573,633,799,400.00/yr
Blended yield
94.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRTT
No analyst data
Altman Z
2.3
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRTT buys
0
JNJ buys
0
No recent congressional trades found for PRTT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRTTJNJ
Forward yield3636.36%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$2866463184412.34M$20.0K
Annual income after 10y$2,719,355,147,267,598,000.00$827.78
Total dividends collected$2856387447109.89M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRTT vs JNJ ($10,000, DRIP)

YearPRTT PortfolioPRTT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$374,336$363,636.36$10,676$355.77+$363.7KPRTT
2$13,122,252$12,721,711.59$11,407$389.39+$13.11MPRTT
3$430,821,997$416,781,187.80$12,198$426.53+$430.81MPRTT
4$13,249,309,769$12,788,330,232.42$13,056$467.62+$13249.30MPRTT
5$381,734,397,300$367,557,635,846.92$13,987$513.12+$381734.38MPRTT
6$10,305,595,787,232$9,897,139,982,121.38$14,998$563.56+$10305595.77MPRTT
7$260,738,028,023,917$249,711,040,531,578.75$16,098$619.52+$260738028.01MPRTT
8$6,183,518,404,581,653$5,904,528,714,596,061.00$17,295$681.69+$6183518404.56MPRTT
9$137,484,146,864,247,860$130,867,782,171,345,470.00$18,599$750.82+$137484146864.23MPRTT
10$2,866,463,184,412,343,000$2,719,355,147,267,598,000.00$20,022$827.78+$2866463184412.32MPRTT

PRTT vs JNJ: Complete Analysis 2026

PRTTStock

Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties. The company was formerly known as Pro-Tect, Inc. and changed its name to Protect Pharmaceutical Corporation in March 2010. Protect Pharmaceutical Corporation was founded in 1987 and is based in Las Vegas, Nevada.

Full PRTT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PRTT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRTT vs SCHDPRTT vs JEPIPRTT vs OPRTT vs KOPRTT vs MAINPRTT vs ABBVPRTT vs MRKPRTT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.